These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 25679212

  • 1. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
    Reimão JQ, Oliveira JC, Trinconi CT, Cotrim PC, Coelho AC, Uliana SR.
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003556. PubMed ID: 25679212
    [Abstract] [Full Text] [Related]

  • 2. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F, Avino VC, Galvis-Ovallos F, Pereira-Chioccola VL, Moreira MAB, Romariz APPL, Molla LM, Menz I.
    Parasit Vectors; 2019 Feb 08; 12(1):79. PubMed ID: 30736866
    [Abstract] [Full Text] [Related]

  • 3. A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.
    de Santana FR, da Silva DAM, Katz S, Orikaza CM, Oliveira KC, Barbiéri CL.
    Parasitol Res; 2022 Oct 08; 121(10):2849-2860. PubMed ID: 35997843
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC, Zauli-Nascimento RC, Yokoyama-Yasunaka JK, Katz S, Barbiéri CL, Uliana SR.
    J Antimicrob Chemother; 2009 Feb 08; 63(2):365-8. PubMed ID: 19095684
    [Abstract] [Full Text] [Related]

  • 5. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
    Coelho AC, Oliveira JC, Espada CR, Reimão JQ, Trinconi CT, Uliana SR.
    PLoS Negl Trop Dis; 2016 May 08; 10(5):e0004660. PubMed ID: 27144739
    [Abstract] [Full Text] [Related]

  • 6. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
    Gonçalves G, Campos MP, Gonçalves AS, Medeiros LCS, Figueiredo FB.
    Parasit Vectors; 2021 Dec 09; 14(1):599. PubMed ID: 34886876
    [Abstract] [Full Text] [Related]

  • 7. Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.
    Hendrickx S, Van den Kerkhof M, Mabille D, Cos P, Delputte P, Maes L, Caljon G.
    PLoS Negl Trop Dis; 2017 May 09; 11(5):e0005620. PubMed ID: 28505185
    [Abstract] [Full Text] [Related]

  • 8. Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro.
    Michel G, Ferrua B, Lang T, Maddugoda MP, Munro P, Pomares C, Lemichez E, Marty P.
    PLoS Negl Trop Dis; 2011 Sep 09; 5(9):e1323. PubMed ID: 21931877
    [Abstract] [Full Text] [Related]

  • 9. Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.
    Eberhardt E, Mondelaers A, Hendrickx S, Van den Kerkhof M, Maes L, Caljon G.
    Parasitol Res; 2016 Oct 09; 115(10):4061-70. PubMed ID: 27412759
    [Abstract] [Full Text] [Related]

  • 10. A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis.
    Carnielli JBT, Crouch K, Forrester S, Silva VC, Carvalho SFG, Damasceno JD, Brown E, Dickens NJ, Costa DL, Costa CHN, Dietze R, Jeffares DC, Mottram JC.
    EBioMedicine; 2018 Oct 09; 36():83-91. PubMed ID: 30268832
    [Abstract] [Full Text] [Related]

  • 11. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
    Faucher JF, Morquin D, Reynes J, Chirouze C, Hoen B, Le Moing V.
    Parasitol Int; 2016 Oct 09; 65(5 Pt A):444-6. PubMed ID: 27353022
    [Abstract] [Full Text] [Related]

  • 12. Experimental treatment with sodium stibogluconate of hamsters infected with Leishmania (Leishmania) chagasi and Leishmania (Leishmania) amazonensis.
    de Figueiredo EM, Costa e Silva J, Brazil RP.
    Rev Soc Bras Med Trop; 1999 Oct 09; 32(2):191-3. PubMed ID: 10228371
    [Abstract] [Full Text] [Related]

  • 13. New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates.
    Bhattacharya A, Ouellette M.
    EBioMedicine; 2018 Nov 09; 37():13-14. PubMed ID: 30314891
    [No Abstract] [Full Text] [Related]

  • 14. Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches.
    Rebello KM, Andrade-Neto VV, Gomes CRB, de Souza MVN, Branquinha MH, Santos ALS, Torres-Santos EC, d'Avila-Levy CM.
    Front Cell Infect Microbiol; 2019 Nov 09; 9():229. PubMed ID: 31316919
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
    Reimão JQ, Colombo FA, Pereira-Chioccola VL, Tempone AG.
    Exp Parasitol; 2012 Mar 09; 130(3):195-9. PubMed ID: 22281156
    [Abstract] [Full Text] [Related]

  • 16. Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.
    Hendrickx S, Beyers J, Mondelaers A, Eberhardt E, Lachaud L, Delputte P, Cos P, Maes L.
    J Antimicrob Chemother; 2016 Jul 09; 71(7):1914-21. PubMed ID: 27084919
    [Abstract] [Full Text] [Related]

  • 17. Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity.
    Castelo-Branco PV, Alves HJ, Pontes RL, Maciel-Silva VL, Ferreira Pereira SR.
    Int J Parasitol Drugs Drug Resist; 2019 Apr 09; 9():8-15. PubMed ID: 30578864
    [Abstract] [Full Text] [Related]

  • 18. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
    Costa RR, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Mendonça DVC, Freitas CS, Lage DP, Martins VT, Antinarelli LMR, Machado AS, Bandeira RS, Ludolf F, Santos TTO, Brito RCF, Humbert MV, Menezes-Souza D, Duarte MC, Chávez-Fumagalli MA, Roatt BM, Coimbra ES, Coelho EAF.
    Med Microbiol Immunol; 2021 Jun 09; 210(2-3):133-147. PubMed ID: 33870453
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.
    Andrade HM, Toledo VP, Pinheiro MB, Guimarães TM, Oliveira NC, Castro JA, Silva RN, Amorim AC, Brandão RM, Yoko M, Silva AS, Dumont K, Ribeiro ML, Bartchewsky W, Monte SJ.
    Vet Parasitol; 2011 Sep 27; 181(2-4):83-90. PubMed ID: 21641721
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of visceral leishmaniasis in children].
    Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM.
    Med Trop (Mars); 2007 Feb 27; 67(1):73-8. PubMed ID: 17506279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.